< Terug naar vorige pagina
Publicatie
Ureaplasma urealyticum osteomyelitis of the greater trochanter in a patient with multiple sclerosis using ocrelizumab - a case report
Tijdschriftbijdrage - Tijdschriftartikel
Korte inhoud:Ocrelizumab - a monoclonal anti-CD20 antibody used in treatment of multiple sclerosis (MS) - marks significant progress in treating autoimmune diseases but raises susceptibility to opportunistic infections due to hypogammaglobulinemia. A young MS patient developed osteomyelitis from persistent Ureaplasma urealyticum urethritis, which was diagnosed with specialized polymerase chain reaction and resolved with targeted antibiotics. A multidisciplinary approach is crucial for managing such infections.
Gepubliceerd in: J Bone Jt Infect
ISSN: 2206-3552
Issue: 3
Volume: 9
Pagina's: 167 - 171
Jaar van publicatie:2024
Toegankelijkheid:Open
Reviewstatus:Peerreview